More

    Finance

    Sera Prognostics trial shows reduced preterm birth complications By Investing.com

    SALT LAKE CITY - Sera Prognostics Inc. (NASDAQ: NASDAQ:), a company specializing in pregnancy biomarker information, has announced the publication of...

    New four-day work week experiment cut turnover, improved worker health

    A 15-month trial of the four-day work week in the UK has given proponents of the alternative schedule a big boost as researchers...

    Gravitics lands $125 million order from Axiom

    A pathfinder for Gravitics' 4-meter space station module design in use for developing manufacturing and assembly methods.GraviticsWashington-based startup Gravitics has signed a $125...

    India eyes energy deals with Rosneft and other Russian companies By Reuters

    By Nidhi Verma and Krishn Kaushik NEW DELHI (Reuters) - India wants to strengthen its energy ties with Russia and could seek...

    Wall Street analysts love this recent IPO that’s an AI play in the health care sector

    Wall Street analysts are bullish on recently-launched health care technology stock Tempus AI . On Tuesday, analysts across the Street initiated coverage of...

    Cenntro expands EV production with new California facility By Investing.com

    FREEHOLD, N.J. - Cenntro Inc. (NASDAQ: CENN), an electric commercial vehicle company, has announced the opening of a new assembly and distribution facility...

    Illinois becomes the first state to protect child vloggers

    Many influencer parents like to incorporate their family into their TikToks, YouTube videos and other types of short-form content. But a new law...

    Putin hosts India’s PM to deepen ties, but Ukraine looms over their relationship

    Indian Prime Minister Narendra Modi met President Vladimir Putin in Moscow on Tuesday, seeking to deepen the relationship between the two nuclear powers at...

    Gain Therapeutics reports positive Phase 1 trial results for Parkinson’s treatment By Investing.com

    BETHESDA, Md. - Gain Therapeutics, Inc. (NASDAQ: GANX), a biotech firm engaged in developing allosteric small molecule therapies, has announced the completion of...

    Latest articles

    spot_imgspot_img